You are here
iCAD to Report Third Quarter and Nine Months Ended September 30, 2018 Financial Results on Tuesday, November 13th
NASHUA, N.H., Nov. 06, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter and nine months ended September 30, 2018 after the close of the market and host a conference call at 4:30pm Eastern Time on Tuesday, November 13th.
|Tuesday, November 13th @ 4:30pm Eastern Time|
|Replays available through November 27th:|
In addition, a replay of the call will remain on the Company’s website (www.icadmed.com) until the Company releases its fourth quarter and year ended 2018 financial results.
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
ARPR, on behalf of iCAD, Inc.